The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia

BACKGROUND: Despite the proven benefits of dexamethasone in hospitalized coronavirus disease 2019 (COVID-19) patients, the optimum time for the administration of dexamethasone is unknown. We investigated the progression of COVID-19 pneumonia based on the timing of dexamethasone administration. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyun Woo, Park, Jimyung, Lee, Jung-Kyu, Park, Tae Yeon, Heo, Eun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273022/
https://www.ncbi.nlm.nih.gov/pubmed/34078038
http://dx.doi.org/10.4046/trd.2021.0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273022/
https://www.ncbi.nlm.nih.gov/pubmed/34078038
http://dx.doi.org/10.4046/trd.2021.0009

Ejemplares similares